Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Silver-Russell Dwarfism

What is Silver-Russell Dwarfism?

Silver-Russell Dwarfism, commonly known as Silver-Russell Syndrome (SRS), is a rare growth disorder that begins at the earliest stages of development in the womb and is thus considered a congenital or primordial dwarfism. During pregnancy, the fetus (with the exception of the head) fails to grow normally. After birth, which is often premature, affected infants experience difficulty feeding or reduced appetite and fail to thrive. SRS patients generally have a characteristic triangular-shaped face with a large head in relation to body size (also known as relative macrocephaly) and a small jaw (micrognathia). Patients have short stature throughout their lives, as well as a host of orthopedic, structural, gastrointestinal, and sometimes behavioral or psychosocial issues. The presentation of symptoms can range from mild, with few complications, to severe. Many cases of SRS cannot be linked to a genetic cause, but up to 60% of cases can be linked to abnormalities involving chromosome 7 or 11. Diagnosis is based upon recently-published consensus guidelines, and, though there is no cure, many patients are able to live full and productive lives with symptom management.

 

Synonyms

  • Silver-Russell Syndrome
  • Russell-Silver Syndrome

Silver-Russell Dwarfism, commonly known as Silver-Russell Syndrome (SRS), is a rare growth disorder that begins at the earliest stages of development in the womb and is thus considered a congenital or primordial dwarfism. During pregnancy, the fetus (with the exception of the head) fails to grow normally. After birth, which is often premature, affected infants experience difficulty feeding or reduced appetite and fail to thrive. SRS patients generally have a characteristic triangular-shaped face with a large head in relation to body size (also known as relative macrocephaly) and a small jaw (micrognathia). Patients have short stature throughout their lives, as well as a host of orthopedic, structural, gastrointestinal, and sometimes behavioral or psychosocial issues. The presentation of symptoms can range from mild, with few complications, to severe. Many cases of SRS cannot be linked to a genetic cause, but up to 60% of cases can be linked to abnormalities involving chromosome 7 or 11. Diagnosis is based upon recently-published consensus guidelines, and, though there is no cure, many patients are able to live full and productive lives with symptom management.

Acknowledgement of Silver-Russell Dwarfism has not been added yet.

SRS is estimated to occur in 1:30,000 to 1:100,000 live births.

Name Abbreviation
Silver-Russell Syndrome SRS
Russell-Silver Syndrome RSS

Most cases of SRS are sporadic, meaning there is no family history of disease, and, in many cases, there is no detectable genetic cause. However, abnormalities of chromosome 7 and 11 have been reported in up to 60% of SRS patients. 

Chromosomes are bundles of genetic material, or DNA, that children inherit from their parents. Typically, each person has 23 pairs of chromosomes, with one of each pair inherited from the mother (maternal copy) and the other inherited from the father (paternal copy). Each chromosome has a long (q) and short (p) arm, along which different genes and gene-regulating elements are located. Most genes are active, or expressed, from both the maternal and paternal chromosomes. However, for some genes, called “imprinted genes,” only one copy is active. For imprinted genes, whether the maternal or paternal copy is active depends on imprinting control regions (ICRs).

Some SRS patients have a chromosomal abnormality called maternal uniparental disomy of chromosome 7, abbreviated matUPD7. In this case, 2 maternal (from the mother) copies of chromosome 7 are inherited rather than one maternal and one paternal. This phenomenon is thought to disrupt the normal balance of gene imprinting, causing excess activation of some genes and not enough activation of others. The exact genes involved have not been determined.

Other genetic causes involve abnormalities on chromosome 11p15 (the 15th band on the short arm of chromosome 11). In a large number of cases, there is an imprinting error caused by dysregulation of imprinting control region 1 (ICR1) on the paternal copy of chromosome 11. This dysregulation leads to reduced activation of the IGF2 gene, or insulin-like growth factor II, which is involved in fetal growth and development and may also affect other gene regulatory regions.

In 3-4% of cases, maternal duplication of ICR1 and/or ICR2 are implicated. Among its many targets, ICR2 controls expression of the maternally expressed genes KCNQ1 and CDKN1C. CDKN1C is involved in growth regulation, while KCNQ1 is a potassium channel affecting heart function. 

In about 1% of cases, patients have a mutation directly affecting the CDKN1C gene.

Growth, birth, and puberty
Decreased fetal growth during pregnancy (intrauterine growth restriction)
Premature birth
Poor growth after birth (weight and length <3rd percentile)
Poor appetite and feeding difficulties
Failure to thrive
Delayed bone maturation
Delayed closing of “soft spot” or anterior fontanelle
Early sexual maturation (premature adrenarche)
Increased risk of early puberty

 

Muscular, joint, and motor
Muscle and weight loss due to an underlying condition (cachexia)
Decreased muscle mass
Loss of the healthy, baseline tension or stiffness in the muscles (hypotonia)
Motor delay
Involuntary muscle twitches (myoclonus)
Joint pain (arthralgia)

 

Head and face, orthopedic, dental, and skin
Short stature
Large head size relative to the body (head sparing or relative macrocephaly)
Triangular face shape
Small jaw (micrognathia)
Small mouth with downturned corners
Low-set, posteriorly rotated ears
Prominent forehead
Body asymmetry (hemihypertrophy)
Scoliosis or the abnormal curvature of the pine
Short and in-curving 5th fingers (clinodactyly)
Fingers that cannot be fully straightened (camptodactyly)
Webbing of the second and third toes (syndactyly)
High, narrow palate
Cleft palate
High-pitched voice
Dental abnormalities, including absence of teeth, small teeth (microdontia), or crowding
Blue appearance of the white of the eye during infancy 
Flat, dark patches of skin (Café-au-lait spots)

 

Endocrine 
Increased risk of low blood sugar and increased ketone levels in the urine  (due to fasting and lack of subcutaneous fat). Urine ketone levels are elevated when the body breaks down fat in the absence of sufficient sugar levels.
Insulin resistance
Excessive sweating
Sleep disturbances

 

Genitourinary 
Undescended testes (cryptorchidism). Testes normally develop in the abdomen and descend to the scrotum before birth as the baby develops. However, individuals with SRS may have undescended testes, meaning that the testicles remain in the abdomen as opposed to being located inside the scrotum.
Mislocation of male urethral opening (hypospadias)
Decreased testicular size
Structural kidney abnormalities

 

Gastrointestinal
Inflammation of the esophagus (esophagitis) causing painful swallowing and/or chest pain
Gastroesophageal reflux causing heartburn or indigestion
Constipation
Vomiting or spitting up

 

Neurodevelopment and Psychology
Psychosocial challenges
Attention deficit disorder (ADD)
Learning difficulties
Autism spectrum disorder

Diagnosis of SRS is based on the Netchine-Harbison clinical scoring system (http://www.nature.com/nrendo/journal/v13/n2/full/nrendo.2016.138.html) which uses the following diagnostic criteria:

  1. Small for gestational age

  2. Postnatal growth failure

  3. Relative macrocephaly (large head size at birth)

  4. Protruding forehead

  5. Body asymmetry

  6. Feeding difficulties

The MAGIC Foundation provides free SRS screening using the above scoring system.

Known genetic causes of SRS only account for about 60% of cases. Therefore, a “negative” genetic test cannot exclude an SRS diagnosis. Testing is conducted on chromosomes 7 and 11. Maternal uniparental disomy (matUPD) of chromosome 7 can lead to a diagnosis of SRS. Additionally, abnormalities of chromosome 11 at band p15 can be involved in SRS in four ways:

1) dysregulation of paternal imprinting control region 1 (ICR1)

2) duplication of ICR1 and ICR2 

3) duplication of ICR2

4) mutation of CDKN1C gene

There is no cure for SRS, and treatment consists primarily of symptom management, including physical, occupational, and speech therapy. Patients should consult an orthopedist for body asymmetry and other skeletal abnormalities and seek out specialists for additional problematic symptoms as necessary.

SRS patients are not typically deficient in growth hormone and, therefore, do not generally respond to growth hormone therapy.

Most individuals affected by SRS are able to live full, productive lives while managing symptoms.

Tips or Suggestions of Silver-Russell Dwarfism has not been added yet.
  1. https://rarediseases.org/rare-diseases/russell-silver-syndrome/

  2. https://medlineplus.gov/genetics/condition/russell-silver-syndrome/#causes

  3. https://rarediseases.info.nih.gov/diseases/4870/russell-silver-syndrome 

  4. https://omim.org/entry/616186 

  5. Silver-Russell Syndrome Global Alliance http://silverrussellsyndrome.org/ 

  6. The MAGIC Foundation https://www.magicfoundation.org/

  7. https://www.omim.org/entry/600856?search=cdkn1c&highlight=cdkn1c 

  8. Wakeling EL, Brioude F, Lokulo-Sodipe O, O'Connell SM, Salem J, Bliek J, Canton AP, Chrzanowska KH, Davies JH, Dias RP, Dubern B, Elbracht M, Giabicani E, Grimberg A, Grønskov K, Hokken-Koelega AC, Jorge AA, Kagami M, Linglart A, Maghnie M, Mohnike K, Monk D, Moore GE, Murray PG, Ogata T, Petit IO, Russo S, Said E, Toumba M, Tümer Z, Binder G, Eggermann T, Harbison MD, Temple IK, Mackay DJ, Netchine I. Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol. 2017 Feb;13(2):105-124. doi: 10.1038/nrendo.2016.138. Epub 2016 Sep 2

  9. Bonaldi A, Mazzeu JF, Costa SS, Honjo RS, Bertola DR, Albano LMJ, Furquim IM, Kim CA, Vianna-Morgante AM. Microduplication of the ICR2 Domain at Chromosome11p15 and Familial Silver–Russell Syndrome. Am J Med Genet. 2011 Sept; Part A 155:2479–2483. https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajmg.a.34023

Community Details Update Created by RareshareTeam
Last updated 27 Jul 2021, 04:52 PM

Posted by RareshareTeam
27 Jul 2021, 04:52 PM

Hi everyone!

The Silver-Russell Dwarfism community details have been updated. We added more information about the cause, prevalence, symptoms, diagnosis, and treatment. We hope you find it helpful. 

Best,

The RareShare Team

Welcome. Talk about SRS Created by arisilver
Last updated 6 Jul 2009, 04:45 PM

Posted by arisilver
6 Jul 2009, 04:45 PM

Let's talk about this disorder, our lifes and change opinions with people who have the same disorder as you. Know what he feels and how he carry on with it. Spanish-English

Community Resources
Title Description Date Link
RareShare news link.

Early study points to potential therapeutic avenue for a pair of rare pediatric diseases.

02/13/2021

Clinical Trials


Cords registry

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

  1. Complete the screening form.
  2. Review the informed consent.
  3. Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit sanfordresearch.org/CoRDS to enroll.

Community Leaders

 

Expert Questions

Ask a question

Community User List

I wanna talk with people about this problem, and maybe make some friends.

 

(English or spanish or hebrew, (Spanish is better)

Start a Community


Don't See Your Condition On Rareshare?

Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.

FAQ


Have questions about rareshare?

Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.

Discussion Forum

Community Details Update

Created by RareshareTeam | Last updated 27 Jul 2021, 04:52 PM

Welcome. Talk about SRS

Created by arisilver | Last updated 6 Jul 2009, 04:45 PM


Communities

Our Communities

Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.

FIND YOUR COMMUNITY
Physicians

Our Resources

Our rare disease resources include e-books and podcasts

VIEW OUR EBOOKS

LISTEN TO OUR PODCASTS

VIEW OUR GUIDES

Leaders

Our Community Leaders

Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.